Some N-of-1 trials are conducted as part of clinical care, others are developed as research. For those that are research, unless they are deemed exempt from formal review, a relevant Human Research Ethics Committee or Institutional Review Board should review specific projects before they are approved. N-of-1 trials should also be authorized by institutions before commencing. The level of risk to the patient/participant should guide and determine whether a particular project is exempt from review, subject to a low/negligible risk review, or should be reviewed by a full committee. Research ethics reviewers must develop a heightened ethical sensitivity toward ensuring that a misguided approach to N-of-1 review does not occur. Clinical researchers, institutions and research review committees, should recognize the continuum of clinical care and clinical research, in order to set and act from explicit standards which are consistent with the clinical practice - clinical research continuum. (PsycINFO Database Record (c) 2019 APA, all rights reserved) (Source: chapter)
CITATION STYLE
Crowden, A., Guyatt, G., Stepanov, N., & Vohra, S. (2015). Research Ethics and N-of-1 Trials. In The Essential Guide to N-of-1 Trials in Health (pp. 125–133). Springer Netherlands. https://doi.org/10.1007/978-94-017-7200-6_11
Mendeley helps you to discover research relevant for your work.